These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8774154

  • 1. Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model. The hyperlipemic-hyperglycemic hamster.
    Simionescu M, Popov D, Sima A, Hasu M, Costache G, Faitar S, Vulpanovici A, Stancu C, Stern D, Simionescu N.
    Am J Pathol; 1996 Mar; 148(3):997-1014. PubMed ID: 8774154
    [Abstract] [Full Text] [Related]

  • 2. Pathobiology of the heart in experimental diabetes: immunolocalization of lipoproteins, immunoglobulin G, and advanced glycation endproducts proteins in diabetic and/or hyperlipidemic hamster.
    Sima A, Popov D, Starodub O, Stancu C, Cristea C, Stern D, Simionescu M.
    Lab Invest; 1997 Jul; 77(1):3-18. PubMed ID: 9251674
    [Abstract] [Full Text] [Related]

  • 3. The effects of simultaneous hyperlipemia-hyperglycemia on the resistance arteries, myocardium and kidney glomeruli.
    Costache G, Popov D, Georgescu A, Cenuse M, Jinga VV, Simionescu M.
    J Submicrosc Cytol Pathol; 2000 Jan; 32(1):47-58. PubMed ID: 10877102
    [Abstract] [Full Text] [Related]

  • 4. Beneficial effects of L-arginine supplementation in experimental hyperlipemia-hyperglycemia in the hamster.
    Popov D, Costache G, Georgescu A, Enache M.
    Cell Tissue Res; 2002 Apr; 308(1):109-20. PubMed ID: 12012211
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity.
    Keren P, George J, Shaish A, Levkovitz H, Janakovic Z, Afek A, Goldberg I, Kopolovic J, Keren G, Harats D.
    Diabetes; 2000 Jun; 49(6):1064-9. PubMed ID: 10866061
    [Abstract] [Full Text] [Related]

  • 10. The effect of probucol on atherosclerosis in streptozotocin-induced diabetic-hyperlipidemic APA hamsters in different stages of atherosclerosis.
    Horiuchi K, Takatori A, Inenaga T, Ohta E, Yamanouchi J, Kawamura S, Ishii Y, Kyuwa S, Yoshikawa Y.
    Exp Anim; 2002 Oct; 51(5):457-64. PubMed ID: 12451706
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hyperlipidemia and atherosclerosis in experimental insulinopenic diabetic monkeys.
    Harano Y, Kojima H, Kosugi K, Suzuki M, Harada M, Nakano T, Hidaka H, Kashiwagi A, Torii R, Taniguchi Y.
    Diabetes Res Clin Pract; 1992 Jun; 16(3):163-73. PubMed ID: 1425136
    [Abstract] [Full Text] [Related]

  • 13. The hyperlipemic hamster - a model for testing the anti-atherogenic effect of amlodipine.
    Sima A, Stancu C, Constantinescu E, Ologeanu L, Simionescu M.
    J Cell Mol Med; 2001 Jun; 5(2):153-62. PubMed ID: 12067498
    [Abstract] [Full Text] [Related]

  • 14. Risk factors, endothelial cell turnover and lipid transport in atherogenesis.
    Lin SJ.
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):309-16. PubMed ID: 9037845
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aortic atheromatous lesions developed in APA hamsters with streptozotocin induced diabetes: a new animal model for diabetic atherosclerosis. 1. Histopathological studies.
    Yamanouchi J, Nishida E, Itagaki S, Kawamura S, Doi K, Yoshikawa Y.
    Exp Anim; 2000 Oct; 49(4):259-66. PubMed ID: 11109551
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL.
    Lamharzi N, Renard CB, Kramer F, Pennathur S, Heinecke JW, Chait A, Bornfeldt KE.
    Diabetes; 2004 Dec; 53(12):3217-25. PubMed ID: 15561953
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.